nodes	percent_of_prediction	percent_of_DWPC	metapath
Sevelamer—Dyspepsia—Repaglinide—type 2 diabetes mellitus	0.00294	0.00294	CcSEcCtD
Sevelamer—Rash—Tolbutamide—type 2 diabetes mellitus	0.00289	0.00289	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Repaglinide—type 2 diabetes mellitus	0.00288	0.00288	CcSEcCtD
Sevelamer—Arthralgia—Glipizide—type 2 diabetes mellitus	0.00288	0.00288	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Rosiglitazone—type 2 diabetes mellitus	0.00288	0.00288	CcSEcCtD
Sevelamer—Constipation—Repaglinide—type 2 diabetes mellitus	0.00286	0.00286	CcSEcCtD
Sevelamer—Diarrhoea—Chlorpropamide—type 2 diabetes mellitus	0.00285	0.00285	CcSEcCtD
Sevelamer—Abdominal distension—Metformin—type 2 diabetes mellitus	0.00283	0.00283	CcSEcCtD
Sevelamer—Diarrhoea—Linagliptin—type 2 diabetes mellitus	0.00282	0.00282	CcSEcCtD
Sevelamer—Asthenia—Nateglinide—type 2 diabetes mellitus	0.00277	0.00277	CcSEcCtD
Sevelamer—Arthralgia—Pioglitazone—type 2 diabetes mellitus	0.00276	0.00276	CcSEcCtD
Sevelamer—Diarrhoea—Acarbose—type 2 diabetes mellitus	0.00274	0.00274	CcSEcCtD
Sevelamer—Gastrointestinal pain—Repaglinide—type 2 diabetes mellitus	0.00273	0.00273	CcSEcCtD
Sevelamer—Pruritus—Nateglinide—type 2 diabetes mellitus	0.00273	0.00273	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Rosiglitazone—type 2 diabetes mellitus	0.00273	0.00273	CcSEcCtD
Sevelamer—Fatigue—Rosiglitazone—type 2 diabetes mellitus	0.00272	0.00272	CcSEcCtD
Sevelamer—Nausea—Tolbutamide—type 2 diabetes mellitus	0.00272	0.00272	CcSEcCtD
Sevelamer—Constipation—Rosiglitazone—type 2 diabetes mellitus	0.0027	0.0027	CcSEcCtD
Sevelamer—Arthralgia—Sitagliptin—type 2 diabetes mellitus	0.00268	0.00268	CcSEcCtD
Sevelamer—Abdominal distension—Irbesartan—type 2 diabetes mellitus	0.00267	0.00267	CcSEcCtD
Sevelamer—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.00265	0.00265	CcSEcCtD
Sevelamer—Abdominal pain—Repaglinide—type 2 diabetes mellitus	0.00264	0.00264	CcSEcCtD
Sevelamer—Diarrhoea—Nateglinide—type 2 diabetes mellitus	0.00264	0.00264	CcSEcCtD
Sevelamer—Anorexia—Glipizide—type 2 diabetes mellitus	0.00263	0.00263	CcSEcCtD
Sevelamer—Rash—Chlorpropamide—type 2 diabetes mellitus	0.00263	0.00263	CcSEcCtD
Sevelamer—Rash—Tolazamide—type 2 diabetes mellitus	0.00263	0.00263	CcSEcCtD
Sevelamer—Rash—Linagliptin—type 2 diabetes mellitus	0.0026	0.0026	CcSEcCtD
Sevelamer—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.0026	0.0026	CcSEcCtD
Sevelamer—Vomiting—Acarbose—type 2 diabetes mellitus	0.00254	0.00254	CcSEcCtD
Sevelamer—Rash—Acarbose—type 2 diabetes mellitus	0.00252	0.00252	CcSEcCtD
Sevelamer—Dermatitis—Acarbose—type 2 diabetes mellitus	0.00252	0.00252	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Glipizide—type 2 diabetes mellitus	0.00252	0.00252	CcSEcCtD
Sevelamer—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.00247	0.00247	CcSEcCtD
Sevelamer—Nausea—Tolazamide—type 2 diabetes mellitus	0.00247	0.00247	CcSEcCtD
Sevelamer—Anorexia—Glimepiride—type 2 diabetes mellitus	0.00246	0.00246	CcSEcCtD
Sevelamer—Vomiting—Nateglinide—type 2 diabetes mellitus	0.00245	0.00245	CcSEcCtD
Sevelamer—Rash—Nateglinide—type 2 diabetes mellitus	0.00243	0.00243	CcSEcCtD
Sevelamer—Dyspepsia—Glipizide—type 2 diabetes mellitus	0.00243	0.00243	CcSEcCtD
Sevelamer—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.00243	0.00243	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Pioglitazone—type 2 diabetes mellitus	0.00241	0.00241	CcSEcCtD
Sevelamer—Decreased appetite—Glipizide—type 2 diabetes mellitus	0.0024	0.0024	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Glipizide—type 2 diabetes mellitus	0.00239	0.00239	CcSEcCtD
Sevelamer—Nausea—Acarbose—type 2 diabetes mellitus	0.00238	0.00238	CcSEcCtD
Sevelamer—Constipation—Glipizide—type 2 diabetes mellitus	0.00236	0.00236	CcSEcCtD
Sevelamer—Pain—Glipizide—type 2 diabetes mellitus	0.00236	0.00236	CcSEcCtD
Sevelamer—Pruritus—Repaglinide—type 2 diabetes mellitus	0.00236	0.00236	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Sitagliptin—type 2 diabetes mellitus	0.00234	0.00234	CcSEcCtD
Sevelamer—Flatulence—Gliclazide—type 2 diabetes mellitus	0.00231	0.00231	CcSEcCtD
Sevelamer—Nausea—Nateglinide—type 2 diabetes mellitus	0.00229	0.00229	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.00229	0.00229	CcSEcCtD
Sevelamer—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.00229	0.00229	CcSEcCtD
Sevelamer—Fatigue—Pioglitazone—type 2 diabetes mellitus	0.00228	0.00228	CcSEcCtD
Sevelamer—Dyspepsia—Glimepiride—type 2 diabetes mellitus	0.00227	0.00227	CcSEcCtD
Sevelamer—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.00226	0.00226	CcSEcCtD
Sevelamer—Dyspepsia—Sitagliptin—type 2 diabetes mellitus	0.00226	0.00226	CcSEcCtD
Sevelamer—Gastrointestinal pain—Glipizide—type 2 diabetes mellitus	0.00226	0.00226	CcSEcCtD
Sevelamer—Decreased appetite—Glimepiride—type 2 diabetes mellitus	0.00224	0.00224	CcSEcCtD
Sevelamer—Decreased appetite—Sitagliptin—type 2 diabetes mellitus	0.00223	0.00223	CcSEcCtD
Sevelamer—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.00223	0.00223	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.00223	0.00223	CcSEcCtD
Sevelamer—Fatigue—Glimepiride—type 2 diabetes mellitus	0.00222	0.00222	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.00222	0.00222	CcSEcCtD
Sevelamer—Arthralgia—Glyburide—type 2 diabetes mellitus	0.00222	0.00222	CcSEcCtD
Sevelamer—Anorexia—Bromocriptine—type 2 diabetes mellitus	0.00222	0.00222	CcSEcCtD
Sevelamer—Fatigue—Sitagliptin—type 2 diabetes mellitus	0.00222	0.00222	CcSEcCtD
Sevelamer—Pain—Sitagliptin—type 2 diabetes mellitus	0.0022	0.0022	CcSEcCtD
Sevelamer—Constipation—Sitagliptin—type 2 diabetes mellitus	0.0022	0.0022	CcSEcCtD
Sevelamer—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.00218	0.00218	CcSEcCtD
Sevelamer—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.00216	0.00216	CcSEcCtD
Sevelamer—Vomiting—Repaglinide—type 2 diabetes mellitus	0.00212	0.00212	CcSEcCtD
Sevelamer—Flatulence—Valsartan—type 2 diabetes mellitus	0.00212	0.00212	CcSEcCtD
Sevelamer—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.00211	0.00211	CcSEcCtD
Sevelamer—Rash—Repaglinide—type 2 diabetes mellitus	0.00211	0.00211	CcSEcCtD
Sevelamer—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.0021	0.0021	CcSEcCtD
Sevelamer—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.0021	0.0021	CcSEcCtD
Sevelamer—Flatulence—Orlistat—type 2 diabetes mellitus	0.00209	0.00209	CcSEcCtD
Sevelamer—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.00205	0.00205	CcSEcCtD
Sevelamer—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.00204	0.00204	CcSEcCtD
Sevelamer—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.00203	0.00203	CcSEcCtD
Sevelamer—Anorexia—Glyburide—type 2 diabetes mellitus	0.00203	0.00203	CcSEcCtD
Sevelamer—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.00202	0.00202	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.00201	0.00201	CcSEcCtD
Sevelamer—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.00201	0.00201	CcSEcCtD
Sevelamer—Arthralgia—Gliclazide—type 2 diabetes mellitus	0.00199	0.00199	CcSEcCtD
Sevelamer—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00199	0.00199	CcSEcCtD
Sevelamer—Constipation—Bromocriptine—type 2 diabetes mellitus	0.00199	0.00199	CcSEcCtD
Sevelamer—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00199	0.00199	CcSEcCtD
Sevelamer—Nausea—Repaglinide—type 2 diabetes mellitus	0.00198	0.00198	CcSEcCtD
Sevelamer—Asthenia—Glipizide—type 2 diabetes mellitus	0.00198	0.00198	CcSEcCtD
Sevelamer—Pruritus—Glipizide—type 2 diabetes mellitus	0.00196	0.00196	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.00194	0.00194	CcSEcCtD
Sevelamer—Flatulence—Metformin—type 2 diabetes mellitus	0.00193	0.00193	CcSEcCtD
Sevelamer—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.0019	0.0019	CcSEcCtD
Sevelamer—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.0019	0.0019	CcSEcCtD
Sevelamer—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.00189	0.00189	CcSEcCtD
Sevelamer—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00188	0.00188	CcSEcCtD
Sevelamer—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.00187	0.00187	CcSEcCtD
Sevelamer—Asthenia—Glimepiride—type 2 diabetes mellitus	0.00185	0.00185	CcSEcCtD
Sevelamer—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.00185	0.00185	CcSEcCtD
Sevelamer—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.00184	0.00184	CcSEcCtD
Sevelamer—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.00184	0.00184	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.00184	0.00184	CcSEcCtD
Sevelamer—Arthralgia—Valsartan—type 2 diabetes mellitus	0.00183	0.00183	CcSEcCtD
Sevelamer—Pruritus—Glimepiride—type 2 diabetes mellitus	0.00182	0.00182	CcSEcCtD
Sevelamer—Flatulence—Irbesartan—type 2 diabetes mellitus	0.00182	0.00182	CcSEcCtD
Sevelamer—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.00181	0.00181	CcSEcCtD
Sevelamer—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.00176	0.00176	CcSEcCtD
Sevelamer—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.00176	0.00176	CcSEcCtD
Sevelamer—Vomiting—Glipizide—type 2 diabetes mellitus	0.00176	0.00176	CcSEcCtD
Sevelamer—Rash—Glipizide—type 2 diabetes mellitus	0.00174	0.00174	CcSEcCtD
Sevelamer—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00174	0.00174	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.00174	0.00174	CcSEcCtD
Sevelamer—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.00174	0.00174	CcSEcCtD
Sevelamer—Flatulence—Losartan—type 2 diabetes mellitus	0.00171	0.00171	CcSEcCtD
Sevelamer—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.00168	0.00168	CcSEcCtD
Sevelamer—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.00168	0.00168	CcSEcCtD
Sevelamer—Anorexia—Valsartan—type 2 diabetes mellitus	0.00167	0.00167	CcSEcCtD
Sevelamer—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.00167	0.00167	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.00165	0.00165	CcSEcCtD
Sevelamer—Fatigue—Gliclazide—type 2 diabetes mellitus	0.00165	0.00165	CcSEcCtD
Sevelamer—Nausea—Glipizide—type 2 diabetes mellitus	0.00164	0.00164	CcSEcCtD
Sevelamer—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00164	0.00164	CcSEcCtD
Sevelamer—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00163	0.00163	CcSEcCtD
Sevelamer—Pain—Gliclazide—type 2 diabetes mellitus	0.00163	0.00163	CcSEcCtD
Sevelamer—Constipation—Gliclazide—type 2 diabetes mellitus	0.00163	0.00163	CcSEcCtD
Sevelamer—Rash—Glimepiride—type 2 diabetes mellitus	0.00163	0.00163	CcSEcCtD
Sevelamer—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00162	0.00162	CcSEcCtD
Sevelamer—Rash—Sitagliptin—type 2 diabetes mellitus	0.00162	0.00162	CcSEcCtD
Sevelamer—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00162	0.00162	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.0016	0.0016	CcSEcCtD
Sevelamer—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.00159	0.00159	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.00158	0.00158	CcSEcCtD
Sevelamer—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.00157	0.00157	CcSEcCtD
Sevelamer—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.00156	0.00156	CcSEcCtD
Sevelamer—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.00154	0.00154	CcSEcCtD
Sevelamer—Nausea—Glimepiride—type 2 diabetes mellitus	0.00153	0.00153	CcSEcCtD
Sevelamer—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00153	0.00153	CcSEcCtD
Sevelamer—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.00153	0.00153	CcSEcCtD
Sevelamer—Asthenia—Glyburide—type 2 diabetes mellitus	0.00153	0.00153	CcSEcCtD
Sevelamer—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.00153	0.00153	CcSEcCtD
Sevelamer—Anorexia—Metformin—type 2 diabetes mellitus	0.00152	0.00152	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.00151	0.00151	CcSEcCtD
Sevelamer—Fatigue—Valsartan—type 2 diabetes mellitus	0.00151	0.00151	CcSEcCtD
Sevelamer—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.00151	0.00151	CcSEcCtD
Sevelamer—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.00151	0.00151	CcSEcCtD
Sevelamer—Pruritus—Glyburide—type 2 diabetes mellitus	0.0015	0.0015	CcSEcCtD
Sevelamer—Constipation—Valsartan—type 2 diabetes mellitus	0.0015	0.0015	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.0015	0.0015	CcSEcCtD
Sevelamer—Fatigue—Orlistat—type 2 diabetes mellitus	0.00149	0.00149	CcSEcCtD
Sevelamer—Pain—Orlistat—type 2 diabetes mellitus	0.00148	0.00148	CcSEcCtD
Sevelamer—Arthralgia—Losartan—type 2 diabetes mellitus	0.00148	0.00148	CcSEcCtD
Sevelamer—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00148	0.00148	CcSEcCtD
Sevelamer—Rash—Bromocriptine—type 2 diabetes mellitus	0.00147	0.00147	CcSEcCtD
Sevelamer—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00147	0.00147	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.00146	0.00146	CcSEcCtD
Sevelamer—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.00146	0.00146	CcSEcCtD
Sevelamer—Anorexia—Irbesartan—type 2 diabetes mellitus	0.00144	0.00144	CcSEcCtD
Sevelamer—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.00143	0.00143	CcSEcCtD
Sevelamer—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.00142	0.00142	CcSEcCtD
Sevelamer—Dyspepsia—Metformin—type 2 diabetes mellitus	0.00141	0.00141	CcSEcCtD
Sevelamer—Decreased appetite—Metformin—type 2 diabetes mellitus	0.00139	0.00139	CcSEcCtD
Sevelamer—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.00139	0.00139	CcSEcCtD
Sevelamer—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00138	0.00138	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.00138	0.00138	CcSEcCtD
Sevelamer—Fatigue—Metformin—type 2 diabetes mellitus	0.00138	0.00138	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.00137	0.00137	CcSEcCtD
Sevelamer—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.00137	0.00137	CcSEcCtD
Sevelamer—Asthenia—Gliclazide—type 2 diabetes mellitus	0.00137	0.00137	CcSEcCtD
Sevelamer—Constipation—Metformin—type 2 diabetes mellitus	0.00137	0.00137	CcSEcCtD
Sevelamer—Anorexia—Losartan—type 2 diabetes mellitus	0.00135	0.00135	CcSEcCtD
Sevelamer—Vomiting—Glyburide—type 2 diabetes mellitus	0.00135	0.00135	CcSEcCtD
Sevelamer—Pruritus—Gliclazide—type 2 diabetes mellitus	0.00135	0.00135	CcSEcCtD
Sevelamer—Rash—Glyburide—type 2 diabetes mellitus	0.00134	0.00134	CcSEcCtD
Sevelamer—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00134	0.00134	CcSEcCtD
Sevelamer—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.00133	0.00133	CcSEcCtD
Sevelamer—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.00131	0.00131	CcSEcCtD
Sevelamer—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.00131	0.00131	CcSEcCtD
Sevelamer—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.00131	0.00131	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.0013	0.0013	CcSEcCtD
Sevelamer—Fatigue—Irbesartan—type 2 diabetes mellitus	0.0013	0.0013	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.00129	0.00129	CcSEcCtD
Sevelamer—Pain—Irbesartan—type 2 diabetes mellitus	0.00129	0.00129	CcSEcCtD
Sevelamer—Constipation—Irbesartan—type 2 diabetes mellitus	0.00129	0.00129	CcSEcCtD
Sevelamer—Arthralgia—Ramipril—type 2 diabetes mellitus	0.00127	0.00127	CcSEcCtD
Sevelamer—Nausea—Glyburide—type 2 diabetes mellitus	0.00126	0.00126	CcSEcCtD
Sevelamer—Abdominal pain—Metformin—type 2 diabetes mellitus	0.00126	0.00126	CcSEcCtD
Sevelamer—Asthenia—Valsartan—type 2 diabetes mellitus	0.00126	0.00126	CcSEcCtD
Sevelamer—Dyspepsia—Losartan—type 2 diabetes mellitus	0.00125	0.00125	CcSEcCtD
Sevelamer—Asthenia—Orlistat—type 2 diabetes mellitus	0.00124	0.00124	CcSEcCtD
Sevelamer—Pruritus—Valsartan—type 2 diabetes mellitus	0.00124	0.00124	CcSEcCtD
Sevelamer—Decreased appetite—Losartan—type 2 diabetes mellitus	0.00123	0.00123	CcSEcCtD
Sevelamer—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.00123	0.00123	CcSEcCtD
Sevelamer—Pruritus—Orlistat—type 2 diabetes mellitus	0.00123	0.00123	CcSEcCtD
Sevelamer—Fatigue—Losartan—type 2 diabetes mellitus	0.00122	0.00122	CcSEcCtD
Sevelamer—Vomiting—Gliclazide—type 2 diabetes mellitus	0.00121	0.00121	CcSEcCtD
Sevelamer—Pain—Losartan—type 2 diabetes mellitus	0.00121	0.00121	CcSEcCtD
Sevelamer—Constipation—Losartan—type 2 diabetes mellitus	0.00121	0.00121	CcSEcCtD
Sevelamer—Rash—Gliclazide—type 2 diabetes mellitus	0.0012	0.0012	CcSEcCtD
Sevelamer—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.0012	0.0012	CcSEcCtD
Sevelamer—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.0012	0.0012	CcSEcCtD
Sevelamer—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.00119	0.00119	CcSEcCtD
Sevelamer—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.00119	0.00119	CcSEcCtD
Sevelamer—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.00116	0.00116	CcSEcCtD
Sevelamer—Anorexia—Ramipril—type 2 diabetes mellitus	0.00116	0.00116	CcSEcCtD
Sevelamer—Asthenia—Metformin—type 2 diabetes mellitus	0.00115	0.00115	CcSEcCtD
Sevelamer—Nausea—Gliclazide—type 2 diabetes mellitus	0.00113	0.00113	CcSEcCtD
Sevelamer—Pruritus—Metformin—type 2 diabetes mellitus	0.00113	0.00113	CcSEcCtD
Sevelamer—Abdominal pain—Losartan—type 2 diabetes mellitus	0.00112	0.00112	CcSEcCtD
Sevelamer—Vomiting—Valsartan—type 2 diabetes mellitus	0.00112	0.00112	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.00111	0.00111	CcSEcCtD
Sevelamer—Rash—Valsartan—type 2 diabetes mellitus	0.00111	0.00111	CcSEcCtD
Sevelamer—Dermatitis—Valsartan—type 2 diabetes mellitus	0.00111	0.00111	CcSEcCtD
Sevelamer—Vomiting—Orlistat—type 2 diabetes mellitus	0.0011	0.0011	CcSEcCtD
Sevelamer—Diarrhoea—Metformin—type 2 diabetes mellitus	0.00109	0.00109	CcSEcCtD
Sevelamer—Rash—Orlistat—type 2 diabetes mellitus	0.00109	0.00109	CcSEcCtD
Sevelamer—Dermatitis—Orlistat—type 2 diabetes mellitus	0.00109	0.00109	CcSEcCtD
Sevelamer—Asthenia—Irbesartan—type 2 diabetes mellitus	0.00108	0.00108	CcSEcCtD
Sevelamer—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.00107	0.00107	CcSEcCtD
Sevelamer—Pruritus—Irbesartan—type 2 diabetes mellitus	0.00107	0.00107	CcSEcCtD
Sevelamer—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.00106	0.00106	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.00105	0.00105	CcSEcCtD
Sevelamer—Fatigue—Ramipril—type 2 diabetes mellitus	0.00105	0.00105	CcSEcCtD
Sevelamer—Nausea—Valsartan—type 2 diabetes mellitus	0.00104	0.00104	CcSEcCtD
Sevelamer—Constipation—Ramipril—type 2 diabetes mellitus	0.00104	0.00104	CcSEcCtD
Sevelamer—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.00103	0.00103	CcSEcCtD
Sevelamer—Nausea—Orlistat—type 2 diabetes mellitus	0.00103	0.00103	CcSEcCtD
Sevelamer—Asthenia—Losartan—type 2 diabetes mellitus	0.00102	0.00102	CcSEcCtD
Sevelamer—Vomiting—Metformin—type 2 diabetes mellitus	0.00102	0.00102	CcSEcCtD
Sevelamer—Rash—Metformin—type 2 diabetes mellitus	0.00101	0.00101	CcSEcCtD
Sevelamer—Dermatitis—Metformin—type 2 diabetes mellitus	0.00101	0.00101	CcSEcCtD
Sevelamer—Pruritus—Losartan—type 2 diabetes mellitus	0.001	0.001	CcSEcCtD
Sevelamer—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000995	0.000995	CcSEcCtD
Sevelamer—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000971	0.000971	CcSEcCtD
Sevelamer—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000962	0.000962	CcSEcCtD
Sevelamer—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000959	0.000959	CcSEcCtD
Sevelamer—Rash—Irbesartan—type 2 diabetes mellitus	0.000951	0.000951	CcSEcCtD
Sevelamer—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.00095	0.00095	CcSEcCtD
Sevelamer—Nausea—Metformin—type 2 diabetes mellitus	0.000949	0.000949	CcSEcCtD
Sevelamer—Vomiting—Losartan—type 2 diabetes mellitus	0.000902	0.000902	CcSEcCtD
Sevelamer—Nausea—Irbesartan—type 2 diabetes mellitus	0.000896	0.000896	CcSEcCtD
Sevelamer—Rash—Losartan—type 2 diabetes mellitus	0.000895	0.000895	CcSEcCtD
Sevelamer—Dermatitis—Losartan—type 2 diabetes mellitus	0.000894	0.000894	CcSEcCtD
Sevelamer—Asthenia—Ramipril—type 2 diabetes mellitus	0.000873	0.000873	CcSEcCtD
Sevelamer—Pruritus—Ramipril—type 2 diabetes mellitus	0.000861	0.000861	CcSEcCtD
Sevelamer—Nausea—Losartan—type 2 diabetes mellitus	0.000843	0.000843	CcSEcCtD
Sevelamer—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000832	0.000832	CcSEcCtD
Sevelamer—Vomiting—Ramipril—type 2 diabetes mellitus	0.000774	0.000774	CcSEcCtD
Sevelamer—Rash—Ramipril—type 2 diabetes mellitus	0.000767	0.000767	CcSEcCtD
Sevelamer—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000766	0.000766	CcSEcCtD
Sevelamer—Nausea—Ramipril—type 2 diabetes mellitus	0.000723	0.000723	CcSEcCtD
